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Abstract Lucigenin (LC +) is frequently used as a Superoxide 
probe. To detect Superoxide, lucigenin must be reduced to the 
lucigenin cation radical (LC+). We show, using the phosphoryl-
ated spin trap 5-diethoxyphosphoryl-5-methyl-l-pyrroline TV-
oxide (DEPMPO), that lucigenin stimulates NADPH-dependent 
Superoxide production by endothelial nitric oxide synthase 
(eNOS). The formation of the DEPMPO-superoxide adduct is 
calcium/calmodulin independent. DEPMPO-superoxide adduct 
formation is inhibited by diphenyleneiodonium and is abolished 
by Superoxide dismutase. It is likely that eNOS/NADPH can 
reduce lucigenin to LC'+ which reduces oxygen to Superoxide. 
Consequently, lucigenin cannot be used to measure Superoxide 
formation. 
©1997 Federation of European Biochemical Societies. 
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1. Introduction 
Lucigenin (bis-A-methylacridinium nitrate, Fig. 1) is an ac-
ridine-based probe that has been used extensively to detect 
Superoxide [1,2]. The reaction between Superoxide and lucige-
nin has been shown to generate chemiluminescence in enzy-
matic and cellular systems. For example, lucigenin has been 
used to detect Superoxide production from NADPH-oxidase 
in phagocytic cells, NADH-dehydrogenase in mitochondria, 
NADPH-cytochrome P450 reductase in microsomes, and 
from xanthine oxidase and NAD(P)H oxidases in endothelial 
and vascular smooth muscle cells [2-11]. The proposed mech-
anism for the evolution of chemiluminescence involves the 
one-electron reduction of lucigenin to form the lucigenin cat-
ion radical (LC+, Fig. 1). This radical reacts with Superoxide 
to form a dioxethane intermediate which decays by a light-
emitting process (Eqs. 1 and 2). 
L C 2 + + e - ^ L C , + (1) 
LC"+ + 0"2" -> Products + Light (2) 
Evidence suggests that Superoxide cannot reduce lucigenin to 
the cation radical [12]. Consequently, Superoxide alone will 
not stimulate chemiluminescence from lucigenin and an addi-
tional reducing agent is required. In several systems, including 
xanthine/xanthine oxidase and NAD(P)H/NAD(P)H-oxidase, 
it is assumed that the enzyme catalyzes the reduction of luci-
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genin to the cation radical intermediate. However, in most 
systems the mechanism of lucigenin reduction is unknown. 
Electron transfer between reduced flavoproteins and xeno-
biotics is a well known phenomenon [13]. For example, viol-
ogens such as paraquat (PQ2+, Fig. 1) can be reduced to the 
corresponding cation radicals by flavoproteins in the presence 
of NAD(P)H. The paraquat cation radical (PQ'+, Fig. 1) is an 
unstable species and undergoes futile redox-cycling, reducing 
oxygen to Superoxide (Eq. 3). In this way paraquat provides a 
kinetic mechanism for the one-electron reduction of oxygen 
by NAD(P)H. 
P Q 2 + ^ P Q - + ^ PQ2+ + 0-- (3) 
The close structural similarity between lucigenin and para-
quat (Fig. 1) suggests that the lucigenin cation radial should 
also be unstable in the presence of oxygen and that lucigenin 
may act as a redox-cycling agent that generates Superoxide 
anion radical. To investigate whether reduction of lucigenin 
can also give rise to Superoxide formation we have used the 
electron spin resonance (ESR) spin-trapping technique incor-
porating the spin trap 5-diethoxyphosphoryl-5-methyl-l-pyr-
roline /V-oxide (DEPMPO, Fig. 1). The Superoxide adduct of 
DEPMPO is fifteen times more stable than that of the more 
commonly used spin trap 5,5'-dimethyl-l-pyrroline A-oxide 
(DMPO). Moreover, unlike the DMPO-superoxide adduct, 
the DEPMPO-superoxide adduct does not spontaneously de-
cay to the DEPMPO-hydroxyl radical adduct. Consequently, 
the steady state level of the DEPMPO-superoxide adduct is 
higher than the DMPO-superoxide adduct at the same rate of 
Superoxide anion generation [14]. 
In this study we have examined the production of super-
oxide by endothelial nitric oxide synthase (eNOS)-dependent 
reduction of lucigenin. eNOS consists of a flavin-containing 
reductase domain and a heme-containing oxidase domain 
[15,16]. NADPH reduces the flavin component of the reduc-
tase domain but electron transfer to heme will not occur un-
less calcium/calmodulin is present. In the presence of calcium/ 
calmodulin, the reductase and oxidase domains align allowing 
electron transfer from the flavins to the heme [16]. In the 
presence of arginine (the physiological substrate for eNOS) 
electrons flow to the heme moiety of the oxidase domain to 
activate oxygen which is used oxidize arginine to citrulline and 
nitric oxide. However, in the absence of arginine, low levels of 
Superoxide are generated by dissociation of the heme-peroxo 
complex (Väsquez-Vivar, Hogg, Martasek, Kalyanaraman 
and Pritchard Jr., unpublished results). 
We show here that eNOS-dependent Superoxide production 
is greatly enhanced by lucigenin and is calcium/calmodulin 
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independent. We propose that Superoxide production occurs 
as a result of the reduction of oxygen by the lucigenin cation 
radical. Consequently any system that reduces lucigenin to the 
lucigenin cation radical can lead to the formation of super-
oxide. As the formation of the lucigenin cation radical is a 
prerequisite for Superoxide detection [12], lucigenin is an un-
reliable probe for Superoxide anion production in biological 
systems. 
2. Materials and methods 
2.1. Materials 
Lucigenin was obtained from Aldrich Chemical Co. (Milwaukee, 
WI), NADPH and L-arginine were obtained from Sigma Chemical 
Co. (St. Louis, MO), diphenyleneiodonium chloride was obtained 
from Calbiochem (San Diego, CA) and L-[14C]arginine was obtained 
from Dupont NEN (Boston, MA). DEPMPO was a gift from Oxis 
International Inc. (Portland, OR). eNOS was purified as previously 
described [15] but including an additional HPLC purification step 
(Superose 6 HR 10/30 column, Pharmacia Biotech AB, Uppsala, Swe-
den). The top fractions of a peak corresponding to the eNOS dimer 
were collected and concentrated. The preparation had an absorbance 
ratio (280 nm/407 nm) of 2.3-2.4 and was >95% pure based on 
sodium dodecyl sulfate polyacrylamide gel electrophoresis. 
2.2. ESR measurements 
ESR spectra were recorded at room temperature on a Varian E-109 
spectrometer at 9.5 GHz employing 100 kHz field modulation. A 
typical incubation mixture for ESR analysis consisted of eNOS (20 
pmol), lucigenin (20 uM), NADPH (0.1 mM) diethylenetriaminepen-
taacetic acid (DTPA, 0.1 mM) and DEPMPO (50 mM) in HEPES 
buffer (50 mM, pH 7.4) in a total volume of 0.2 ml. Reactions were 
initiated by the addition of enzyme and quickly transferred to a 
quartz flat cell for ESR analysis. Computer-based simulations of 
ESR spectra were performed using software written by D. Duling [17]. 
2.3. Biochemical assays 
eNOS activity was determined by monitoring the conversion of L-
[14C]arginine to L-[14C]citrulline as previously described [18]. Briefly, 
reaction mixtures containing HEPES (50 mM, pH 7.4), DTPA (0.1 
mM), calcium chloride (0.4 mM), calmodulin (10 ug/ml), tetrahydro-
biopterin (10 uM), flavin adenine dinucleotide (1 uM), flavin mono-
nucleotide (1 uM), bovine serum albumin (100 ug/ml), L-[14C]arginine 
(100 uM, 0.83 uCi), NADPH (0.5 mM) and glutathione (0.1 mM) 
were incubated with eNOS (18 pmol), and formation of L-
[14C]citrulline was measured by liquid scintillation counting [18]. 
NADPH oxidation was monitored spectrophotometrically 
(Amax = 340 nm, e = 6.22 mM -1 cm-1). Reaction mixtures contained 
HEPES (50 mM, pH 7.4), DTPA (0.1 mM), lucigenin (20 uM), cal-
cium chloride (0.1 mM), calmodulin (18 ug/ml) and eNOS (20 pmol). 
3. Results 
3.1. Activity of purified bovine eNOS 
The activity of eNOS was monitored by following the for-
mation of L-[14C]citrulline from L-[14C]arginine. The specific 
activity of the enzyme was 394 nmol citrulline/min/mg protein 
at 25°C. 
3.2. eNOS-mediated NADPH oxidation in the absence and 
presence of lucigenin 
When NADPH was added to an incubation containing ei-
ther lucigenin or eNOS, negligible consumption of NADPH 
was observed (Fig. 2A,B). However, the combination of luci-
genin and eNOS caused a complete oxidation of NADPH 
within 25 min (Fig. 2C). When lucigenin was added to 
eNOS in the presence of calcium/calmodulin a similar rate 
of NADPH oxidation was observed (data not shown). These 
results suggest that eNOS catalyzes lucigenin-dependent 
Lucigenin (LC++) Lucigenin cation 
radical (LC*) 
Paraquat (PQ++) Paraquat cation 
radical (PO/) 
(EtO) 2 (0)P_^ + 
H3C 
DEPMPO 
Fig. 1. Chemical structures. 
NADPH oxidation. Diphenyleneiodonium, a specific flavo-
protein reductase inhibitor, completely inhibited lucigenin-
stimulated oxidation of NADPH by eNOS (Fig. 2D). This 
indicates that lucigenin enhances NADPH oxidation by ac-
cepting electrons from the reductase domain of eNOS. 
3.3. Spin-trapping of Superoxide anion from the reduction of 
lucigenin 
Addition of NADPH to an incubation mixture containing 
eNOS, and the spin trap, DEPMPO, in HEPES buffer did not 
produce detectable levels of the DEPMPO-superoxide adduct 
(Fig. 3A). However, addition of lucigenin to the same incu-
bation mixture produced an intense ESR signal corresponding 
to that of the DEPMPO-superoxide adduct (Fig. 3B). Fig. 3B 
shows a computer simulation of the two major diastereo-
isomers (63% of isomer I and 37% of isomer II) of the 
DEPMPO-superoxide adduct whose hyperfine coupling con-
stants are (in Gauss: aN = 13.1, aßH = 10.7, ap=49.2 for iso-
mer I and aN = 13.1, apH = 11.6, ap = 50.9 for isomer II) in 
accordance with previously reported values [14]. An identical 
ESR spectrum to that shown in Fig. 3B was observed if eNOS 
was incubated with NADPH, DEPMPO and lucigenin in the 
presence of calcium/calmodulin (data not shown). The 
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Fig. 2. NADPH consumption by eNOS in the presence and absence 
of lucigenin. NADPH was incubated in HEPES (50 mM, pH 7.4) 
containing DTPA (0.1 mM) at 25°C in the presence of (A) lucigenin 
(20 uM), (B) eNOS (20 pmol), (C) lucigenin (20 uM) and eNOS (20 
pmol), and (D) lucigenin (20 uM), eNOS (20 pmol) and diphenyl-
eneiodonium (100 uM). NADPH consumption was monitored at 
340 nm. Data are representative of at least two independent experi-
ments. 
DEPMPO-superoxide adduct signal intensity was diminished 
if the solution was purged with nitrogen before analysis (Fig. 
3C) and abolished by the addition of SOD (Fig. 3D). These 
results indicate that the DEPMPO-superoxide adduct is 
formed by trapping Superoxide anion and that Superoxide 
formation depends upon the presence of eNOS, NADPH 
and lucigenin. 
In order to determine if the flavoprotein component of 
eNOS is involved in the lucigenin-dependent generation of 
Superoxide, we performed spin-trapping experiments in the 
presence of diphenyleneiodonium, a flavoprotein reductase in-
hibitor. This compound inhibited the spectral intensity of the 
DEPMPO-superoxide adduct in a concentration-dependent 
manner (Fig. 4A-C), indicating that the reductase domain 
of eNOS reduces lucigenin. 
4. Discussion 
4.1. Lucigenin-dependent Superoxide production 
It has previously been reported that the interaction between 
Superoxide and the lucigenin cation radical, but not lucigenin, 
gives rise to chemiluminescence [12]. Consequently, lucigenin 
must form a cation radical before it can react with Superoxide 
to form light-emitting products (Eqs. 1 and 2). However, the 
reaction between the lucigenin cation radical and oxygen, to 
produce Superoxide, has not been previously considered. Here 
we have demonstrated that lucigenin generates Superoxide 
anion in the eNOS/NADPH system, under aerobic conditions. 
Lucigenin is a water-soluble acridine-based compound that 
has a reduction potential of —0.4 V in DMSO and -0 .3 V in 
water vs. Ag/AgCl electrode [19]. Analogous to paraquat, 
whose reduction potential at pH 7.0 is about —0.45 V, it is 
likely that lucigenin can be reduced by NADPH-cytochrome 
P450 reductase or the reductase domain of eNOS [20,21]. 
We show here that lucigenin stimulates eNOS-dependent 
NADPH consumption and Superoxide generation. This occurs 
by a mechanism that depends entirely on the flavin compo-
nent of the eNOS reductase domain. The most plausible ex-
planation for lucigenin-stimulated Superoxide production is 
that lucigenin acts as a redox-cycling compound in a manner 
similar to paraquat. By this mechanism, lucigenin is reduced 
to the cation radical (LC'+, Eq. 4) which reacts with oxygen to 
regenerate lucigenin and form Superoxide (Eq. 5). 
NADPH/eNOS + LC i + -> LC 
LC-+ + 0 2 ^ L C
2 + + O r 
(4) 
(5) 
In this way, the combination of eNOS and lucigenin catalyzes 
the NADPH-dependent reduction of oxygen to Superoxide. 
The detailed mechanism of lucigenin-dependent Superoxide 
production in this system is currently under investigation. 
4.2. Lucigenin as a probe for Superoxide 
A considerable body of literature on vascular generation of 
Superoxide has been obtained using the lucigenin chemilumi-
nescence assay [3,9-11]. This assay is popular because it is 
assumed to measure intra- and extracellular Superoxide gen-
eration with high sensitivity and specificity. 
The data shown here indicate that lucigenin-derived chem-
iluminescence can not be attributed to endogenous Superoxide 
production as lucigenin itself can generate Superoxide in the 
presence of flavoprotein reductases or other enzymatic reduc-
20 G 
Fig. 3. Lucigenin-dependent Superoxide formation by eNOS. eNOS 
(20 pmol), NADPH (0.1 mM) and DEPMPO (50 mM) in HEPES 
buffer (50 mM pH 7.4) containing DTPA (0.1 mM), were incubated 
at room temperature: (A) without lucigenin; (B) in the presence 
of lucigenin (20 U.M); (C) as (B) after purging with nitrogen for 
5 min; and (D) as (B) in the presence of SOD (10 ug/ml). Instru-
mental conditions: microwave power, 10 mW; modulation ampli-
tude, 1 G; time constant, 0.128 s; scan rate, 1.67 G/s; and number 
of averaged scans, 5. 
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Fig. 4. Effect of diphenyleneiodonium on lucigenin-dependent super-
oxide formation by eNOS. Incubations of purified eNOS (20 pmol), 
NADPH (0.1 mM), lucigenin (20 uM) and DEPMPO (50 mM) in 
HEPES buffer (50 mM pH 7.4) containing DTPA (0.1 mM), were 
performed at room temperature: (A) without diphenyleneiodonium; 
(B) as (A) in the presence of diphenyleneiodonium (50 uM); (C) as 
(A) in the presence of diphenyleneiodonium (100 uM). Instrumental 
conditions: microwave power, 10 mW; modulation amplitude, 1 G; 
time constant, 0.128 s; scan rate, 1.67 G/s; and number of averaged 
scans, 5. 
ing systems. Consequently lucigenin-dependent chemilumines-
cence is not a specific measure of Superoxide. 
4.3. Biological considerations 
It is likely that redox-cycling xenobiotics such as quinones 
stimulate eNOS-dependent Superoxide production by a similar 
mechanism to that observed with lucigenin (Eqs. 4 and 5). 
Redox metabolism of xenobiotics by eNOS will change the 
activity of eNOS from a nitric oxide synthase to a N A D P H -
oxidase, thus altering the balance between Superoxide and 
nitric oxide in vascular cells. Changes in the rates of produc-
tion of these two radicals have been shown to be an important 
component of vascular pathologies such as atherosclerosis [22] 
and can lead to increased formation of peroxynitrite, a potent 
biological oxidant [23]. 
Addit ion of lucigenin to a biological system may perturb 
the levels of nitric oxide and Superoxide leading to increased 
peroxynitrite formation. The concomitant drain on N A D P H 
levels will also render the cell more susceptible to increased 
oxidative stress. 
4.4. Summary 
The ESR spin-trapping da ta show unambiguously that lu-
cigenin can mediate flavoprotein reductase-dependent super-
oxide production. Consequently, lucigenin can not be used as 
a probe to detect Superoxide production in biological systems. 
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